Summary : A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
company
-
-
Summary : As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play.…
-
RegulatoryU.S FDA
Aquestive Therapeutics Presented Positive Topline Phase 1 Results for AQST-109 Epinephrine Oral Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
by adminby adminSummary : Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and…
-
Zero Discrimination Day is an observance marked annually on March 1 by United Nations among other international organisations to promote equality and…
-
EuropePharma Science & Research
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
by adminby adminSummary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with…
-
Global MarketPharma Science & Research
Scancell gains new facilities at The Oxford Science Park
by adminby adminSummary : British biotech company Scancell has expanded its research and development capabilities at one of the UK’s leading parks for science…
-
RegulatoryU.S FDA
GC Pharma Receives Complete Response Letter From the U.S. FDA For ‘ALYGLO’
by adminby adminSummary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug…
-
Summary : The Committee for Medicinal Products for Human Use (CHMP) has provided an initial assessment of Valneva’s inactivated, adjuvanted COVID-19 vaccine…
-
CompaniesPharma Science & ResearchTakeda
Takeda-Backed Biotech Grabs $24 Million for tRNA-Based Therapies
by adminby adminSummary : hC Bioscience, Inc., a company focused on discovering and developing tRNA-based therapies, announced that it has raised $24 million in…
-
AstraZenecaCompaniesGlobal MarketPharma Science & Research
AstraZeneca in the News: EMA Greenlights RSV Vaccine, Leif Johansson Departing
by adminby adminSummary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab from the European Medicines Agency. Nirsevimab was…